دورية أكاديمية
Treatment of moderate‐to‐severe plaque psoriasis with tildrakizumab in the real‐life setting
| العنوان: | Treatment of moderate‐to‐severe plaque psoriasis with tildrakizumab in the real‐life setting |
|---|---|
| المؤلفون: | Alessio Gambardella, Gaetano Licata, Alina De Rosa, Giulia Calabrese, Roberto Alfano, Giuseppe Argenziano |
| المصدر: | JEADV Clinical Practice, Vol 2, Iss 1, Pp 52-58 (2023) |
| بيانات النشر: | Wiley, 2023. |
| سنة النشر: | 2023 |
| المجموعة: | LCC:Dermatology LCC:Diseases of the genitourinary system. Urology |
| مصطلحات موضوعية: | biological drugs, DLQI, PASI, plaque psoriasis, quality of life, real life, Dermatology, RL1-803, Diseases of the genitourinary system. Urology, RC870-923 |
| الوصف: | Abstract Background Information is lacking from real‐life studies evaluating the efficacy of tildrakizumab in moderate‐to‐severe psoriasis. Materials and Methods We retrospectively analysed a database of 30 patients with moderate‐to‐severe psoriasis (PsO) that were treated with tildrakizumab (100 mg, s.c.) and followed for 36 weeks. Clinical efficacy (disease severity and treatment response) was evaluated by the Psoriasis Area and Severity Index (PASI) at baseline and after 4, 12, 24, and 36 weeks. The quality of life (QoL) of PsO patients was measured using the Dermatology Life Quality Index (DLQI). Results A PASI score of |
| نوع الوثيقة: | article |
| وصف الملف: | electronic resource |
| اللغة: | English |
| تدمد: | 2768-6566 |
| Relation: | https://doaj.org/toc/2768-6566 |
| DOI: | 10.1002/jvc2.65 |
| URL الوصول: | https://doaj.org/article/7d1735a3694c4f40a60023e66ede5d32 |
| رقم الأكسشن: | edsdoj.7d1735a3694c4f40a60023e66ede5d32 |
| قاعدة البيانات: | Directory of Open Access Journals |
Full Text Finder | تدمد: | 27686566 |
|---|---|
| DOI: | 10.1002/jvc2.65 |